Paid Clinical Trials in Flint, MI
As of September 2026, 141 paid clinical trials are recruiting in Flint, Michigan. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Flint offers studies at sites including Genesys Hurley Cancer Institute for conditions such as Stage IV Lung Cancer AJCC v8, Acute Myeloid Leukemia, Anatomic Stage II Breast Cancer AJCC v8, Lung Non-Small Cell Carcinoma. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Flint
Trials by drug in Flint
Filter results
Newly added in Flint
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
135 clinical trials
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Pelacarsen Roll-over Extension Program
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension
C-Brace Prospective Registry
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum
REal-world Clinical evAulation of Medtronic NeurOVascular Products for Acute Ischemic Stroke (RECANOVA Registry)
NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Family Communications After Genetic Testing
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
The Cancer Stage Shifting Initiative: Registry and Biorepository to Research and Address Health Disparities in Cancer Care
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
Top Research Study Locations in Flint
Researchers run research studies in Flint, MI at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Genesys Hurley Cancer Institute | Acute Myeloid Leukemia, Anatomic Stage II Breast Cancer AJCC v8, Stage IV Lung Cancer AJCC v8 | 69 |
| Cancer Hematology Centers - Flint | Acute Myeloid Leukemia, Anatomic Stage II Breast Cancer AJCC v8, Stage IV Lung Cancer AJCC v8 | 59 |
| Hurley Medical Center | Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 58 |
| Genesee Hematology Oncology PC | Malignant Solid Neoplasm, Melanoma, Non-Hodgkin Lymphoma | 27 |
| McLaren Cancer Institute-Flint | Metastatic Malignant Neoplasm in the Brain, Stage IV Lung Cancer AJCC v8, Advanced Esophageal Adenocarcinoma | 11 |
| Karmanos Cancer Institute at McLaren Flint | HER2-negative Breast Cancer, Hormone Receptor Positive Tumor, Advanced Breast Cancer | 7 |
| AA Medical Research Center | Aortic Stenosis, Cardiovascular Disease and Lipoprotein(a), Moderate to Severe Chronic Obstructive Pulmonary Disease | 4 |
| Genesee Cancer and Blood Disease Treatment Center | Anatomic Stage IV Breast Cancer AJCC v8, Castration-Resistant Prostate Carcinoma, Elevated CA15-3 or CEA or CA27-29 | 4 |
| McLaren Proton Therapy Center | Breast Cancer, Breast Neoplasm, Breast Tumor | 4 |
| Aa Mrc Llc | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Difficult to Control Hypertension | 3 |
| Michigan State University | Colorectal Cancer, Health Disparities, Maternal Morbidity and Mortality | 3 |
| AA Medical Research Center (MRC) | Atrial Fibrillation (AF) | 2 |
| Elite Research Center | Cardiovascular Risk, Type 1 Diabetes Mellitus With Hypoglycemia, Type 2 Diabetes | 2 |
| AA MRC LLC Ahmed Arif Medical Research Center | Systemic Lupus Erythematosus (SLE) | 1 |
| Aa Mrc Mhs | Atherosclerotic Cardiovascular Disease | 1 |
| Ahmed Arif Medical Research Center (AA MRC LLC ) | Atherosclerosis | 1 |
| Aurinia Investigational Site | Myasthenia Gravis, Generalized | 1 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| Corazon Imaging | Atherosclerosis, Cardiovascular Inflammation, Coronary Artery Disease | 1 |
| Dermatology & Cosmetic Center PLLC - Flint | Pyoderma Gangrenosum | 1 |
| Dermatology and Cosmetic Center | NonSegmental Vitiligo | 1 |
| Elite Clinical Research Center | Hypothyroidism | 1 |
| Elite Research Center, LLC | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension | 1 |
| Flint Development Center | Cardiovascular Health, Health Promotion | 1 |
| Flint Journal Building | HPV Vaccination | 1 |
Active & Upcoming Studies in Flint (2026)
Recruiting trials in Flint grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (79 active studies)
- A Study of the TheraBionic P1 Device in Breast Cancer · Barbara Ann Karmanos Cancer Institute
- Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial · Phase 3 · National Cancer Institute (NCI)
Cardiovascular (9 active studies)
- A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF · Phase 3 · AstraZeneca
- Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable · Phase 3 · Regeneron Pharmaceuticals
Diabetes & metabolic (4 active studies)
- AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications · Phase 3 · Novo Nordisk A/S
- A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity · Phase 3 · Pfizer
Mental health & behavior (2 active studies)
- The ROSE Scale-up Study: Informing a Decision About ROSE as Universal PPD Prevention · Michigan State University
- Testing Adaptive Interventions to Improve Posttraumatic Stress Disorder Treatment Outcomes in Federally Qualified Health Centers · University of Michigan
Neurology & pain (2 active studies)
- REal-world Clinical evAulation of Medtronic NeurOVascular Products for Acute Ischemic Stroke (RECANOVA Registry) · Medtronic Neurovascular Clinical Affairs
- Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial · Phase 3 · Mercy Health Ohio
Eye & vision (1 active study)
- Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (SIGHT) 2 · University of Michigan
Common conditions studied in Flint
- Stage IV Lung Cancer AJCC v8 (7 active studies)
- Acute Myeloid Leukemia (6 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (5 active studies)
- Lung Non-Small Cell Carcinoma (4 active studies)
- Recurrent Lung Non-Small Cell Carcinoma (4 active studies)
- Stage IIIB Lung Cancer AJCC v8 (4 active studies)
Leading research sponsors in Flint
- National Cancer Institute (NCI)
- Alliance for Clinical Trials in Oncology
- SWOG Cancer Research Network
- NRG Oncology
- Barbara Ann Karmanos Cancer Institute
Frequently asked questions
How many paid clinical trials are currently recruiting in Flint?
There are approximately 141 recruiting clinical trials in Flint, Michigan listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Flint pay participants?
Most recruiting trials in Flint compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Flint?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Flint?
The most common conditions under active study in Flint include Stage IV Lung Cancer AJCC v8 (7), Acute Myeloid Leukemia (6), Anatomic Stage II Breast Cancer AJCC v8 (5), Lung Non-Small Cell Carcinoma (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Flint?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Flint on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Flint?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Flint?
Recruiting research sites in Flint include Genesys Hurley Cancer Institute, Cancer Hematology Centers - Flint, Hurley Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Flint right now?
The largest active categories in Flint are Cancer & tumors (79), Cardiovascular (9), Diabetes & metabolic (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.